Atlas Trials

LEV102 Topical Gel in Acquired Blepharoptosis

Clinical trial NCT05715346 · COMPLETED

Trial details

NCT number
NCT05715346
Sponsor
Levation Pharma, Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acquired Blepharoptosis
Start date
2023-02-23
Primary completion
2023-06-24
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.